Mariam Sultani | xSr. Director
xSeagen Pfizer

Mariam Sultani is a global pharmaceutical manufacturing and planning leader with experience across Pfizer/Seagen and Johnson & Johnson based in Switzerland. She has led integrated planning, external manufacturing, and supply governance across complex global biologics and oncology networks, including CDMOs and multiple clinical and commercial assets. Her work focuses on connecting pipeline strategy, capacity, manufacturing readiness, and risk management to enable successful launches and resilient patient supply.

Appearances:

Festival of Biologics Day 3 @ 12:20

Fill-Finish 2030: Turning Pipeline Uncertainty into Flexible, Resilient Supply

The principal fill-finish challenges facing pharmaceutical companies today, including capacity constraints, demand volatility, long qualification timelines, device complexity, and reliance on concentrated supplier and CDMO networks.
How to design the right capacity portfolio across dedicated high-speed lines, flexible multi-format platforms, and external manufacturing—connecting pipeline scenarios with make-versus-buy and network decisions.
The capabilities that will matter most over the next five years, including barrier and robotic processing, platform standardisation, prefilled syringes and devices, digital execution, and greater supply-chain redundancy.

Mariam Sultani, xSr. Director, xSeagen Pfizer

last published: 21/Sep/26 11:05 GMT

back to speakers